Monash Private Capital
Level 14, 167 Macquarie Street, Sydney, New South Wales, 2000, Australia
Overview
Monash Private Capital is a Sydney based independent principal investment and advisory firm providing capital, asset management and strategic advisory solutions. Their key areas of business include real estate, private equity, venture capital and independent advisory services to high net worth and corporate clients. The foundations of Monash Private Capital stem from the strong credentials, proven track record and deep relationships of its shareholders and key executives. They have a flexible and creative approach to opportunities with an ability to make nimble decisions supported by a robust risk management and governance framework.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 4
Sector focus
- Financial Services
Investment portfolio
- All G Foods
Participated · Series A · Aug 2022
All G Foods is developing high-value milk proteins through a proprietary precision-fermentation platform, allowing it to create bovine and human lactoferrin with high purity (>95%) and scalable yields. The company has completed pilot-scale production of recombinant bovine lactoferrin, has self-affirmed GRAS status for adult nutrition in the U.S., and secured approval for personal-care use in China. Its first commercial product, a bovine lactoferrin powder, is planned for launch in late 2025, followed by human lactoferrin in early 2026. To accelerate scale-up and commercialization, All G formed a joint venture with French dairy-bioactives leader Armor Protéines, leveraging Armor’s manufacturing expertise and global distribution relationships. All G has filed multiple patents covering micelle assembly, scalable manufacture and human milk compositions. The company’s technology aims to lower costs, improve supply stability and broaden access to lactoferrin, which traditionally requires thousands of litres of cow’s milk per kilogram produced. Headquartered in Waterloo, New South Wales, the firm positions itself at the intersection of early-life nutrition, adult health supplements and precision-fermented bioactives.
- Bellabox
Participated · Equity · Mar 2014
Bellabox is a beauty subscription site that curates and ships monthly boxes of beauty samples to members. Founded in October 2011 by sisters Sarah and Emily Hamilton, the company claims 70% market share in Australia and has 40,000 monthly members in Australia and Singapore. The startup reports 12% month-over-month subscriber growth. Bellabox emphasizes market research, customization and data-driven targeting to differentiate from traditional sampling services. Management says it will use new capital to expand service offerings, improve market research, hire staff and enter new Asia Pacific markets. The company also aims to integrate with publishers and advertisers to drive a "discover and then buy" e-commerce experience for beauty brands. Bellabox operates a mailed monthly beauty-samples subscription box and an accompanying online store. The company positions itself as a marketing and sales service for brands, using its subscription boxes and online channel rather than branding as a traditional beauty company. Co-founder and CEO Sarah Hamilton describes the business as primarily logistics, marketing and related services. Bellabox grew its subscriber base from an initial 350 to over 100,000. To fund that growth the company raised $1.3 million in expansion capital at the beginning of 2013 from a range of investors. The company framed not spending the $1.3M quickly as a beneficial mistake.